An Historical Overview of Second Trimester Abortion Methods

References

• TD Kerenyi, N Mandelman, D Scherman. Five thousand consecutive saline induction. American Journal of Obstetrics and Gynecology. 116: 1973; 593–600.
   Google Scholar
• TD Kerenyi. Intraamniotic techniques. JE Hodgson. Abortion and Sterilization. 1981; Academic Press: New York, 359–377.
   Google Scholar
• M Bygdeman, N Wiquist. Induction of mid-trimester abortion by intra-amniotic administration of PGF2α. Acta Physiologica Scandinavica. 82: 1971; 415–416.
   PubMedGoogle Scholar
• SMM Karim, SD Sharma. Second trimester abortion with single intra-amniotic injection of prostaglandin E2 or F2. Lancet. ii: 1971; 47–48.
   Google Scholar
• M Bygdeman. Pharmacokinetics of prostaglandin. Best Practice & Research Clinical Obstetrics & Gynecology. 17: 2003; 707–716.
   PubMed Web of Science ®Google Scholar
• WHO Prostaglandin Task Force. Comparison of intra-amniotic prostaglandin F2α and hypertonic saline for induction of second-trimester abortion. British Medical Journal. 2: 1976; 1373–1376.
   Google Scholar
• D Edelman, W Brenner, A Metha. A comparative study of intraamniotic saline and two prostaglandin F2α dose schedules for midtrimester abortion. American Journal of Obstetrics and Gynecology. 125: 1976; 188–195.
   Web of Science ®Google Scholar
• B Gustavii, K Green. Release of prostaglandin F2α following injection of hypertonic saline for therapeutic abortion: a preliminary study. American Journal of Obstetrics and Gynecology. 114: 1972; 1099–1100.
   Web of Science ®Google Scholar
• M Toppozada, AA Ismail. Intra-uterine administration of drugs for termination of pregnancy in the second trimester. Baillière's Clinical Obstetrics and Gynecology. 4: 1990; 327–349.
   Google Scholar
• RT Burkman, NH Dubin, TM King. The use of hyperosmolar urea for the elective abortion of mid-trimester pregnancy. GI Zatuchni, JJ Sciarra, JJ Speidel. Pregnancy termination. 1979; Harper and Row: Hagerstown, 261–267.
   Google Scholar
• Prostaglandin Task Force. Comparison of single intra-amniotic injection of 15-methyl prostaglandin F2α for termination of second-trimester pregnancy: an international, multicenter study. American Journal of Obstetrics and Gynecology. 129: 1977; 601–606.
   Web of Science ®Google Scholar
• Y Manabe. Artificial abortion at midpregnancy for mechanical stimulation of the uterus. American Journal of Obstetrics and Gynecology. 105: 1969; 132–146.
   PubMed Web of Science ®Google Scholar
• B Gustavii, G Hauff, U Brunk. Rivanol induced alterations of cultured cells. Contraception. 16: 1977; 89–96.
   Web of Science ®Google Scholar
• CA Ingemanson. The ethacridine-catheter method in second trimester abortion. GJ Zatuchni, JJ Sciarra, JJ Speidel. Pregnancy termination. 1979; Harper and Row: Hagerstown, 282–289.
   Google Scholar
• N Wiquist, M Bygdeman. Therapeutic abortion by local administration of prostaglandin. Lancet. ii: 1970; 716–717.
   Google Scholar
• N Wiquist, F Beguin, M Bygdeman. Induction of abortion by extra-amniotic prostaglandin administration. Prostaglandins. 1: 1972; 37–43.
   Google Scholar
• WHO Prostaglandin Task Force. Single extra-amniotic administration of 15-methyl prostaglandin F2α in Hyscon for termination of pregnancies in weeks 10 to 20 of gestation: An international multicenter study. American Journal of Obstetrics and Gynecology. 129: 1977; 597–600.
   Web of Science ®Google Scholar
• NH Lauerson, KH Wilson. Termination of mid-trimester pregnancy by serial injections of 15(S)-15-methyl PGF2α. American Journal of Obstetrics and Gynecology. 123: 1976; 169–176.
   Google Scholar
• WHO Prostaglandin Task Force. Intramucular administration of 15-methyl PGF2α for induction of abortion in weeks 10 to 20 of pregnancy. American Journal of Obstetrics and Gynecology. 129: 1977; 593–596.
   Web of Science ®Google Scholar
• WHO Prostaglandin Task Force. Termination of second-trimester pregnancy by intramuscular injection of 16.phenoxy-w-17,18,19,20-tetranor-PGE2 methyl sulphonylamide. International Journal of Gynecology and Obstetrics. 20: 1982; 383–386.
   Web of Science ®Google Scholar
• M Bygdeman, NJ Christensen. Termination of second-trimester pregnancy by laminaria and intramuscular injection of 15-metyl PGF2α or 16-phenoxy-w-17,18,19,20-tetranor PGE2 methylsolfonylamide. Acta Obstetricia Gynecologica Scandinavica. 62: 1983; 535–536.
   PubMed Web of Science ®Google Scholar
• JP Lebed, A Rubin, AE Millman. Comparison between intra-amniotic PGF2α and vaginal PGE2 for second trimester abortion. Obstetrics and Gynecology. 56: 1980; 90–96.
   Web of Science ®Google Scholar
• WHO Prostaglandin Task Force. Repeated vaginal administration of 15-methyl PGF2α methylester for termination of pregnancy in the 13th to 20th week of gestation. Contraception. 16: 1977; 175–181.
   Web of Science ®Google Scholar
• V Dimov, K Green, M Bygdeman. Metabolism of 16,16-dimethyl-trans-Δ2–PGE1 methylester following intravenous and vaginal administration to pregnant women. Drug Metabolism and Disposition. 14: 1986; 494–502.
   Web of Science ®Google Scholar
• KJ Thong, AJ Robertson, DT Baird. A retrospective study of 932 second trimester terminations using gemeprost. Prostaglandins. 44: 1992; 65–74.
   Google Scholar
• K Gemzell-Danielsson, S Lalitkumar. Second trimester medical abortion with mifepristone-misoprostol and misoprostol alone: a review of methods and management. Reproductive Health Matters. 16(31 Suppl): 2008; 162–172.
   PubMed Web of Science ®Google Scholar
• NJ Binkin. Trends in induced legal abortion morbidity and mortality. Clinical Obstetrics and Gynaecology. 13: 1986; 83–94.
   Google Scholar
• PA Lohr. Surgical abortion in the second trimester. Reproductive Health Matters. 16(31 Suppl): 2008; 151–161.
   Web of Science ®Google Scholar
• M Bygdeman. Comparison of prostaglandin and hypertonic saline for termination of pregnancy. Obstetrics and Gynecology. 52: 1978; 424–429.
   Web of Science ®Google Scholar
• R Lowensohn, CA Ballard. Cervico vaginal fistula. An apparent increased incidence with prostaglandin F2α. American Journal of Obstetrics and Gynecology. 119: 1974; 1057–1061.
   PubMed Web of Science ®Google Scholar
• DA Grimes, KF Schulz, W Cates. Midtrimester abortion by intraamniotic prostaglandin F2α: Safer than saline?. Obstetrics and Gynecology. 49: 1977; 612–616.
   Web of Science ®Google Scholar
• LL Su, A Biswas, M Choolani. A prospective, randomized comparison of vaginal misoprostol versus intra-amniotic prostaglandins for midtrimester termination of pregnancy. Obstetrics and Gynecology. 193: 2005; 1410–1414.
   Web of Science ®Google Scholar
• A Velazco Boza, R Gómez Ponce de León, L Salas Castillo. Misoprostol preferable to ethacridine lactate for abortions at 13–20 weeks of pregnancy: Cuban experience. Reproductive Health Matters. 16(31 Suppl): 2008; 189–195.
   Web of Science ®Google Scholar
• JK Jain, DR Mishell. A comparison of intravaginal misopostol with prostaglandin E2 for termination of second trimester pregnncy. New England Journal of Medicine. 33: 1994; 290–293.
   Google Scholar
• PS Ramsey, K Savage, T Lincoln. Vaginal misoprostol versus concentrated oxytocin and vaginal PGE2 for second trimester labour induction. Obstetrics and Gynecology. 104: 2004; 138–145.
   PubMed Web of Science ®Google Scholar
• KS Wong, CSW Ngai, AYK Wong. Vaginal misoprostol compared with vaginal gemeprost in termination of second trimester pregnancy. A randomized trial. Contraception. 58: 1998; 207–210.
   PubMed Web of Science ®Google Scholar
• IM Dodd, CA Crowther. Misoprostol versus cervagem for the induction of labour to terminate pregnancy in the second and third trimester. A systemic review. European Journal of Obstetrics & Gynecology and Reproductive Biology. 125: 2006; 3–8.
   PubMed Web of Science ®Google Scholar
• PA Lohr, JL Hayes, K Gemzell-Danielsson. Surgical versus medical methods for second trimester induced abortion. Cochrane Database Syst Rev. 1: 2008 Jan 23; CD006714.
   Web of Science ®Google Scholar
• Safe Abortion: Technical and Policy Guidance for Health Systems. World Health Organization, Geneva 2003.
   Google Scholar